Fig. 6
The effect of ROLEO and ROLME on the MCF-7, HepG2, and MCF-10A cells morphology. Cells were exposed to 100 μg/mL of ROLEO and ROLME for 48 h. (A) represents MCF-7 non-treated cells, (B) represents MCF-7-treated cells with positive control (cisplatin 30 µg/mL), (C) represents MCF-7 -treated cells with ROLEO, (D) represents MCF-7 -treated cells with ROLME, (E) represents HepG2 non-treated cells, (F) = represents HepG2-treated cells with positive control (cisplatin 30 µg/mL), (G) represents HepG2-treated cells with ROLEO, (H) represents HepG2-treated cells with ROLME, (I) represents MCF-10A non-treated cells, (J) = represents MCF-10A -treated cells with positive control (cisplatin 30 µg/mL), (K) represents MCF-10A -treated cells with ROLEO , (L) represents MCF-10A -treated cells with ROLME. (Magnification power 10X).
